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ANALYSIS OF DTC GENETIC FITNESS TESTS    
Abstract 
Based on current scientific literature, Direct-to-Consumer (DTC) genetic tests for fitness 
capability generally lack validation and have little predictive value. We aimed to evaluate DTC 
genetic fitness testing companies found through Google searches. Website information including 
genes tested and claims made by the companies was collected. In total, thirty-one companies 
were evaluated. Only 8 of 31 companies identify genes being tested and of these 8, only 4 cite 
any scientific literature. The 6 most common genes tested (MCGT) were ​ACE, ACTN3, AGT, 
FTO, IL6​,​ ​and ​PPARG​. The 5 most common claims (MCC) were ​genetically tailored nutrition, 
genetically tailored workout, information on injury risk, personalized fitness program,​ and 
response to training​. Given the lack of information provided by the companies, we cannot fully 
assess the claims, and can only express skepticism about the limited value of such testing as per 
the current scientific literature. Therefore, more research is needed to better understand genetic 
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An Analysis of Fitness Affiliated Direct-To-Consumer Genetic Tests 
Introduction 
Since the first full sequencing of the human genome in 2003, the cost of genetic 
sequencing has continuously decreased (Allyse, Robinson, Ferber, & Sharp, 2018). Decreasing 
costs have resulted in the development of a new market sector, with companies selling genetic 
information to consumers, using the internet as well as brick and mortar retail options (Harris, 
Kelly, & Wyatt, 2013). This business model is known as direct-to-consumer (DTC) genetic 
testing and manifests itself in a variety of products, such as ancestry testing, health testing and 
carrier testing (Phillips, 2016).  
One increasingly common type of DTC genetic test is trait testing for fitness capability; 
however, genetic fitness tests generally lack validation and have little predictive value (Phillips, 
2016). In the past, at-home saliva test kits were seen as commercial purchases rather than 
medical tests, so informed consent was not required and “there were no clear regulatory 
mechanisms in place to assess the analytical validity, clinical validity, and clinical utility” 
(Allyse et al., 2018 p. 116). Without validation studies or supporting research, DTC genetic 
testing companies have blazed their own trails in the scientific and business communities.  
Regulation of DTC Genetic Tests 
In 2010, the Food & Drug Administration (FDA) asserted its right to regulate DTC 
genetic tests based on the 1976 Medical Device Amendments to the Food, Drug, and Cosmetic 
Act. The FDA requested the companies apply for premarket approval and noted that they no 
longer intended to exempt such tests from more stringent regulations.  In a 2017 reassessment, 
then FDA Commissioner Scott Gottlieb outlined a pathway for DTC genetic tests for genetic 
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health risks to be evaluated and thus enter the marketplace upon approval, indicating the FDA’s 
intention to differentiate between low risk, moderate risk and high risk genetic testing. 
According to the FDA website, DTC genetic tests relating to athletic ability are a “low risk 
general wellness product” and that they do not “generally” review these types of tests 
(​https://www.fda.gov/medical-devices/vitro- diagnostics/direct-consumer-tests​, date accessed: 
8/11/19). As labs performing DTC genetics tests are not being held to the same analytic 
standards as other types of testing, the accuracy and reliability of such testing is questionable 
(Lippi, Favaloro, & Plebani, 2011).  
Marketing of DTC Genetic Tests 
The argument has been made that DTC companies manipulate “consumer 
identity-seeking” (Caulfield & McGuire, 2012, p. 28) by marketing the idea that a person’s 
genetic construct determines much about them and that useful information can be drawn from 
their DNA. False and overstated claims are frequently made in order to lure consumers, which 
Murray et al (2010) describes as operating “under the protective cloak of legitimate science” (p. 
459) and Spencer and Topol (2019) call “faux scientific authority” (p. 45).  
The complexity of genetic testing and its implications makes it difficult to be confident 
consumers are fully informed of the risks, benefits, and limitations of such testing (Hawkins & 
Ho, 2012). Most traits are multifactorial and may be subject to epigenetic and environmental 
effects, so that genetic testing provides results that are difficult to interpret and easily 
misunderstood by consumers (Hawkins & Ho, 2012). As Harris et al states, “One common point 
of concern is how individuals may (mis)understand, (mis)interpret and cope with the genetic 
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information that they are provided from genetic tests not ordered through a healthcare 
professional” (Harris et al., 2013, p. 277).  
DTC Genetic Fitness Tests 
At the beginning of 2016, Phillips reported that 246 companies were offering online 
DNA tests, 38 of which were categorized as testing for athletics. The first known study of these 
tests was published in 2013; the UK-based team of Williams, Heffernan, and Day (2014) 
performed internet searches to identify 22 DTC genetic fitness tests then available to the public. 
The genes most frequently tested for by these companies were polymorphisms in the ​ACTN3​ (11 
of 22 companies) and ​ACE ​(6 of 22 companies) genes - ​ACTN3 ​being tagged as the ‘speed gene’ 
since it had been identified as more common in speed and power sport athletes (Williams et al., 
2014). Williams et al. (2014) indicated that 9 of the 22 companies they looked at did not make 
public information on which genetic variants were included in their test. DTC companies that do 
not disclose which variants they assess have been criticized because they make it impossible for 
academics or consumers to assess the test’s validity (Webborn et al., 2015).  
Webborn et al. (2015) also conducted internet searches intended to imitate what a 
potential consumer might do. The authors found that the relevance of genetic variants to 
athleticism were not made clear on the websites and required subjective interpretation (Webborn 
et al., 2015). The most commonly tested variant in these tests was ​ACTN3​ ​R577X,​ and the second 
most commonly tested variant was ​ACE I/D ​(Webborn et al., 2015)​. ​Claims made by these 
companies in the study on their websites were generally lacking in scientific support (Webborn 
et al., 2015). Studies noted by companies that did provide citations were often not representative 
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of the literature as a whole – something that likely would be difficult for customers to evaluate – 
and variant interpretation was inconsistent across different companies (Spencer & Topol, 2019).  
Genes of Interest for Fitness 
There are a variety of genes of interest that play a role in athleticism and DTC genetic 
fitness companies claim to use various subsets of these genes to predict athletic ability and 
individual response to exercise. Some of the most frequently cited genes that appear to impact 
athleticism are ​ACE, ACTN3, AGT, FTO, IL6,​ and​ PPARG​. 
ACE​. ​The ​ACE​ gene ​plays a role in controlling blood pressure by regulating body fluid 
levels (Puthucheary et al., 2011). Variants in ​ACE I​ have been implicated in exaggerated 
response to training regimens, cardiac growth in response to a stimulus, and greater strength 
gains in response to training (Puthucheary et al., 2011). ​Research shows mixed results in regards 
to the significance of the ​I ​and ​D ​alleles. A meta analysis by Ma et al. (2013) found a significant 
association between the ​I/I ​genotype and endurance performance, whereas the ​D ​allele was 
associated with strength and performance in power related events. Other smaller studies also 
observed a higher frequency of the ​D ​allele among sprint type athletes (Nazarov et al., 2001; 
Papadimitriou et al, 2016). However, the long distance runners in the Nazarov et al. (2001) study 
had similar genotypes to controls, rather than a bias towards the ​I ​allele as other studies had 
observed. Two other studies involved elite endurance athletes from widely different sports such 
as cycling, gymnastics, and hockey, and found no notable differences in genotype frequencies 
between their athletes and controls (Rankinen et al., 2000; Taylor, Mamotte, Fallon, & Van 
Bockxmeer, 1999).  
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ACTN3​. ​The ​ACTN3​ gene codes for a protein found in fast-twitch muscle fibers that is 
activated during short bursts of activity such as sprinting (Lee, Houweling, North, & Quinlan, 
2016). ​North et al. (1999) first reported a relationship between athletic performance and the 
R577X nonsense mutation, which is carried by a​pproximately 20% of the world’s population 
(Lee et al., 2016). It has been argued that the ​R ​allele is advantageous in power type events, 
noting that in some studies the ​RR ​genotype is overrepresented in power athletes whereas the ​XX 
genotype is associated with lower muscle strength and lower sprinting ability (Kikuchi & 
Nakaz​ato, 2015). 
Alfred et al. (2011) concluded that the ​RR ​genotype is more common among both sprint 
and power athletes whereas Ma et al. (2013) found a significant association between the ​RR 
genotype and power events only. Power athletes have also been found to be approximately 50% 
less likely to have the ​XX ​genotype (Eynon et al., 2012; Druzhevskaya, Ahmetov, Astratenkova, 
& Rogozkin, 2008). In contrast, evidence for the association between the ​XX ​genotype and 
endurance capability is weaker. One study found an underrepresentation of the ​XX ​genotype 
amongst endurance athletes; moreover, they found athletes with an ​RR ​genotype outperformed 
those with an ​RX ​genotype in an endurance exercise (Ahmetov et al., 2010). Another study also 
found no association between ​XX ​and endurance ability among Ironman Triathlon participants 
(Saunders et al., 2007). Based on current literature, there appears to be more consistent data 
supporting an association between ​ACTN3​ power performance and less data supporting an ​XX 
association with endurance performance (Guth & Roth, 2013).  
AGT. ​According to Aleksandra et al, certain ​AGT ​polymorphisms are associated with 
sports performance. Higher levels of the angiotensin II protein, which is associated with 
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improved power and strength performance, were seen in women who carried the ​C ​allele when 
compared to those with the ​TT ​genotype (Aleksandra et al., 2016). However, much of the 
research on​AGT ​relates to hypertension, methamphetamine dependence, and coronary heart 
disease, and there is limited information on its relationship to athletic performance.  
FTO​. ​The ​FTO​ gene has been shown to relate to satiety, and appears to impact the 
likelihood of obesity. One study focused on a population carrying the ​G ​allele at a particular SNP 
and found it correlated with higher BMI (Scuteri, 2007). Another study surveyed children and 
found those with two lower risk ​FTO​ alleles consumed significantly less food than those with 
one or two higher risk alleles (Wardle, 2009). Some researchers also speculate that this gene is 
implicated in athleticism; however, a study by Eynon et al (2013) surveyed athletes and found 
the ​AT ​polymorphism was not associated with elite athletic status.  
IL6​. ​The interleukin-6 gene regulates the body’s IL-6 levels, which are thought to be 
associated with inflammatory diseases (Tanaka, 2014). The frequency of the ​G ​allele and ​GG 
genotype of ​IL6 ​have been documented to be higher among power athletes relative to controls; 
however, no difference in allele frequency has been seen between endurance athletes and 
controls (Ruiz et al., 2010). Eynon et al. (2011a) analyzed ​IL6 ​genotypes and found no 
statistically significant differences amongst any groups and therefore stressed the need for 
replication studies to fully understand any potential associations between specific alleles and 
athletic status or performance.  
PPARG​. ​The ​PPARG ​gene belongs to a family of Peroxisome Proliferator-Activated 
Receptor (PPAR) genes, which have been shown to have an association with certain fitness 
phenotypes (​Leońska-Duniec, Ahmetov, & Zmijewski, 2016)​. The ​PPARG Alanine (Ala) ​allele, 
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compared to the ​Proline (Pro) ​allele, was significantly more common in power athletes relative 
to endurance athletes (​Drozdovska, Dosenko, Ahmetov, & Ilyin, 2013). ​Leońska-Duniec ​et al. 
(2016) found that those with the ​ProPro ​genotype experienced a greater reduction in body fat 
following an aerobic training program relative to ​Ala ​carriers; suggesting the ​Ala ​genotype may 
weaken the beneficial effects of such a training program. The ​Ala ​carriers, on the other hand, 
seemed to benefit more from resistance style training (​Leońska-Duniec et al., 2016). 
Opinions of Genetic Fitness Testing 
With no regulation of DTC genetic fitness tests to provide quality assurance, expert 
opinion on current genotype testing practices for fitness associated phenotypes is particularly 
valuable. Mattsson, Wheeler, Waggott, Caleshu, and Ashley (2016) state that research supporting 
genetic testing for sports is based on too small a sample size: study sizes need to be increased 
and studies replicated so that what is reported is not overestimated. ​Given small homogenous 
cohorts, the results cannot be extrapolated to the general population and should not be utilized in 
such a way (Mattsson et al., 2016). Genome wide association studies (GWAS) looking for single 
nucleotide polymorphisms, or SNPs, for athletic ability typically have small sample sizes 
(N=100-200) as compared to GWAS studies looking into medical conditions such as 
Alzheimer’s, which inherently limits the application to the general population (Eynon, Morán, 
Birk, & Lucia, 2011b). Moreover, ​general research in the field has been performed on 
Caucasian/European participants, thus making the extrapolation of the results more difficult for 
the general population (Vlahovich et al., 2017b). 
Other experts stress that the performance of an athlete is not based solely on his/her 
genetics; rather, a multitude of genetic and non-genetic factors that make up ability (Brooks & 
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Tarini, 2011). In one study, one hundred twenty known genetic alleles that play a role in athletic 
performance were categorized into 77 endurance-related genetic markers and 43 
power/strength-related genetic markers (Ahmetov & Fedotovskaya, 2015). Only 9% of the total 
markers showed a genotype-phenotype relationship with athletic status in three or more studies 
analyzed (Ahmetov & Fedotovskaya, 2015). Whatever benefit there may be from understanding 
this complex genetic information via DTC genetic fitness testing, the lack of sufficient genetic 
counseling available to consumers may present a further limitation (Vlahovich, Fricker, Brown, 
& Hughes, 2017a; Webborn et al., 2015). 
In regards to the ​ACTN3​ genotype, Webborn et al. (2015) state, “Contribution to the 
degree of inter-individual variability in sprinting performance is trivial” (p. 1490) which may 
result in, as Murray et al. (2010) says, manipulation and subjected misuse of scientific 
information. Caulfield (2011) emphatically states that even though there is an underlying basis 
for testing for ​ACTN3​ and fast-twitch muscle fibers, “It is wrong to imply that it is a test for 
athletic ability, a complex, socially constructed and multi-factorial concept, or that it can provide 
anything close to a definitive conclusion about future speed abilities” (p. 3). As Caulfield (2011) 
notes, there will be athletes in the Olympics without the R577 variant and there will be people 
with the R577 variant watching the Olympics from home. 
Methods 
In October 2019, two iterations of an internet search were conducted to identify 
commercially available fitness and exercise related genetic tests. To mimic what a potential 
consumer could find if interested in DTC genetic fitness testing, four English language internet 
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search terms were typed into the internet browser ​www.google.com​: GENETIC, TEST, 
FITNESS, DNA. The websites found in the first ten pages of each search were recorded. 
Each website was examined for the following information, if available: website address, 
name of DTC company, name of the genetic fitness test, genes identified, scientific articles cited, 
general marketing claims, if an FAQ section was present, cost of testing, if previous genetic 
testing results could be imported, and if the company offered nutrition specific genetic testing. 
Data points from each DTC company were entered into a spreadsheet for analysis. Thirty-four 
companies were identified in total, including 3 companies that did not ship to the United States 
and were subsequently excluded from analyses, giving a total of 31 companies assessed. 
Descriptive statistics were employed to examine the type, frequency and evidentiary support of 
claims on behalf of the DTC genetic fitness testing products, and (where possible) the genes 
included for testing. 
Results 
In total, 31 companies were identified with websites that sold DTC genetic fitness tests in 
the U.S. (Table 1). Of the 31 websites, 8 identified the genes tested, noted in bold. One hundred 
forty-five unique genes were included in one or more of these 8 tests (Table 2). The genes ​ACE 
(5)​, ACTN3 ​(7)​, AGT ​(6)​, FTO ​(7)​, IL6 ​(6),​ ​and ​PPARG​ (6) were the 6 most common genes 
tested (MCGT) (Figure 1). Seven websites cited scientific literature while 24 did not (Figure 2). 
Of the 7 websites, 2 websites had 2-5 articles, 1 website had 6-10 articles, and 4 websites had 
11+articles. Only 4 of the 8 websites that identified genes cited any scientific literature (Table 1). 
The 5 most common claims (MCC), seen in at least one third of the websites, were 
genetically tailored nutrition ​(12)​, genetically tailored workout ​(17)​, information on injury risk 
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(14)​, personalized fitness program ​(13)​,​ and ​response to training ​(11) (Figure 3). The cost of 
DTC genetic fitness tests was an average of $182 and ranged from $20 to $399 (Figure 4). Two 
companies with very low cost testing, Xcode and FoundMyFitness ($20 and $25 respectively), 
required consumers to upload their own genetic data file from companies such as 23andme. Four 
websites did not list a price for their test. 
Table 1 - DTC Genetic Fitness Testing Companies Assessed 
DTC 












NutraFit Health & Wellness 
Genetic Test N N 
CALIGENIX caligenix.com Sports Nutrition N N 
Circle DNA circledna.com Vital DNA Test N N 
DNAFit dnafit.com/us Health Fit Y Y 
dnaPower dnapower.com fitPower N N 
DNA Code dnacode.com Fitness & Nutrition N N 
Dnomium dnomium.com Fitness & Nutrition N N 
Easy DNA easydna.ie 
NutriFit Health & Fitness 
DNA Testing N N 
Fitness 
Genes fitnessgenes.com DNA Analysis Y N 
Found My 
Fitness foundmyfitness.com 
Found My Fitness 
Comprehensive Report N N 
Genetic 
Direction geneticdirection.com GxPerform Y Y 
Genovate genovate.com DNA Fitness Test Y N 
GenoVive genoviveusa.com 
Nutrition and Fitness Genetic 
Profile Report N Y 
Health Codes 
DNA healthcodesdna.com Fitness Panel N N 
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Helix helix.com MyTraits Sport for iOS N N 
HomeDNA homedna.com HomeDNA Healthy Weight Y Y 
IDLife idlife.com DNA Bundle N N 
LifeDNA lifedna.com 
LifeDNA Reports + DNA 
Kit N Y 
MiaDNA miadna.com Exercise & Fitness N N 
Molecular 
Fitness mtlfitness.com Molecular Fitness N Y 
myDNA mydna.life/en-us Nutrition & Fitness Y Y 
MyExome myexome.com 
DNA Testing for Fitness, 
Nutrition and Health N N 
Myogenes myogenes.com Diet, Health & Fitness Test N N 
New Life 
Genetics newlifegenetics.com 
DNA Fitness Test for Men, 
DNA Fitness Test for 
Women Y N 
Next Health next-health.com Genetic Fit Testing N N 
Ori askori.com OriFIT + Package N N 
Orig3n shop.orig3n.com Fitness DNA Test Y N 
Original Gene originalgene.com 
Fitness & Healthy Living 
DNA Test N N 
Vitagene vitagene.com Health Plus Ancestry Report N N 
Vitl vitl.com DNA Nutrition Test N N 
Xcode xcode.life Gene Fitness Report N N 
 
Table 2 - All Genes Identified by DTC Genetic Fitness Testing Websites 
ABCB11 CKM GLIS1 LRRN6C PPARG 
ACE CLOCK GNB3 MAP2K5 PPARGC1 
ACTG1 CNTF GNPDA2 MBL2/DKK1 PPM1K 
ACTN3 COL1A1 GPRC5B MC4R PRKD1 
ACVR1B COL5A1 GPX1 MCT1 QPCTL-GIPR 
ADH1C COMT GSTM1 MEPE 
RP11-10017.3-0
01 
ADIPOQ CREB1 GSTT1 MGMT RPL27A 
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ADORA2A CRP HERC2 MSTN SEC16B 
ADRB2 CRP HIF1A MSTNRARE SHBG1 
ADRB2_1 CRY2 HLA MTCH2 SHBG2 
ADRB2_2 CYP1A1 HLA MTHFR SHBGE7 
ADRB3 CYP1A2 HNF1A MTHFR_SNP2 SLC23A1 
AGT CYP2R1 HOXB3 MTIF3 SLC25A13 
AHR DEC(1) IGF1 MTNR1B SLC30A8 
AKT1 DRD2 IGF1_2 MTR SLC39A8 
ALDH2 EC16B IGFBP3 MTRR SLC8A1 
AMPD1 EDN1 IGFS9B NADSYN1 SOD2 
ANNK1 EPHX1 IL15RA NBPF3 SPTBN1 
APOA2 ERP27 IL6 NEGR1 SYT1 
APOA5 ETV5 IL6R NFE2L2 TCF7L2 
APOC1 
(APOE-CI-CII) FABP2 IRS1 NMB TFAP2B 
APOC3 FAIM2 KANSL1 NOS3 TGFA 
APOE FANCL KIF5B NRF2 TNF 
ARID3B FLJ35779 LCT NRXN3 TRHR 
BCM01 FTO LIPC PEX14 UCP2 
BDKRB2 FUT2 LPL PGC1A UCP3 
BDNF GBF1 LRP1B POLD3 VDR 
C18orf19 GC LRP5 PPARA VDR_Taq 
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Figure 1 - Percentages of the 8 DTC Genetic Fitness Testing Companies that List MCGT 
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Figure 3 - Top Claims of DTC Genetic Fitness Testing Companies 
 
 
Figure 4 - Cost of DTC Genetic Fitness Tests 
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Discussion 
Our analysis showed that of 31 DTC genetic fitness tests found online, only 8 companies 
attempted to inform consumers on what genes were included in the test. Without knowledge of 
what genes are being examined, no consumers and no experts can assess the value of the tests for 
sale from those 23 companies, many of which carry a substantial price tag. Among those 8 that 
do list the genes examined, only half offered any references to scientific literature to support 
their choice of targets. Further consideration of the utility of testing, therefore, was only possible 
for four companies that provided both the genes tested and literature to support a scientific 
rationale for testing. 
Genetic Direction​. All of the 6 MCGT are tested here; however, literature was supplied 
only for ​ACE, ACTN3, AGT,​ and ​IL6​. The study available (​Weyerstraß, Stewart, Wesselius, & 
Zeegers, 2018​) ​on the website concluded that there is an association between being a power 
athlete and certain alleles; yet, the authors also suggest that more research is needed on these 
genes to come to any comprehensive conclusions. Despite this caveat, Genetic Direction still 
makes 3 of the 5 MCC: genetically tailored workout, personalized fitness program, and training 
response.  
HomeDNA. ​Of the 6 MCGT, HomeDNA only looks at ​FTO ​and ​PPARG​ and which, 
surprisingly, was noted to not make the claim of genetically tailored nutrition. Instead, the MCC 
made are genetically tailored workout and personalized fitness program. Noted researcher Dr. 
Mark Sarzynski is credited for his research efforts for HomeDNA, but he is also part of the 
Genetic Direction leadership team.  
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myDNA. ​Five of the MCGT are offered by myDNA: ​ACTN3, AGT, FTO, IL6 ​and 
PPARG. ​Scientific literature available on the site mentions ​ACTN3 ​(​Kikuchi & Nakazato, 2015)​, 
AGT ​(​Zarebska et al., 2013)​,​ and ​IL6 ​(Ruiz et al., 2010), among others, for muscle fiber 
composition as well as a study showing the absence of any association between certain 
genotypes and sprint/power performance (Ahmetov, Vinogradova, & Williams, 2012). 
Importantly, myDNA is the only website to list two employed associate genetic counselors on 
their team, but their scope of practice is not discussed. 
The MCC genetically tailored nutrition, information on injury risk, and personalized 
fitness program are made; furthermore, statements are made about the gene variants that myDNA 
tests for but the specific variants are not stated. For example, myDNA calls ACTN3 ‘The Power 
Gene’ and incorrectly states that elite athletes will generally possess the variant of this gene 
associated with explosive fitness movements. It is true that there is an association between elite 
power athletes and the ​RR ​genotype for explosive movements; yet, not all elite athletes will have 
the ​RR ​genotype nor will every sport call for the use of fast-twitch muscle fibers. ​AGT ​is called 
‘The Strength Gene’ and there have been claims that the associated genetic variant is most 
commonly found in power sport Olympians, but this has not been verified. ​IL6 ​is called ‘The 
Recovery Gene’ and there have been claims that the associated genetic variant helps the body 
recover faster from intense exercise, and while this is plausible, it has not been documented in 
the literature in studies of athletes. ​FTO ​and ​PPARG ​are related to food satiety and fat storage, 
respectively, and are described as much on myDNA’s website with marketing claims such as the 
FTO ​gene may be the reason why someone goes back for seconds at the dinner table. 
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DNAfit. ​All of the 6 MCGT are mentioned on the website and scientific references are 
present, the latest from 2019 (Pickering et al.). Authors of the literature cited included two 
employees of DNAfit: Dr. Ildus Ahmetov and Dr. Silvia Camporesi from DNAfit’s Scientific & 
Advisory Team. It is not indicated when Dr. Ahmetov or Dr. Camporesi became employees of 
DNAfit or if their publications were done prior or after that relationship was established.  
The MCC of genetically tailored workout, information on injury risk, personalized fitness 
program, and response to training are made, and akin to myDNA, these claims are tied to the 
genes that DNAfit tests for. This time, however, actual alleles are discussed in such a way to aid 
consumers who are interested in assessing their genetic basis workout recommendations. 
According to DNAfit, the ​I ​and ​D ​alleles of ​ACE ​are the basis of different workout 
recommendations: the ​I/I ​alleles associated with endurance sports and high repetition weight 
training programs and the ​DD ​alleles associated with power based training. These findings have 
been seen in the literature but are not without controversy, as some studies showed no significant 
effect of the ​II ​alleles in endurance training. DNAfit makes claims about ​ACTN3 ​while 
incorrectly labeling the alleles they are looking at, identifying the ​RR ​and ​XX ​alleles as ​CC ​and 
TT​, respectively. The claim made here of the ​XX ​genotype being found more frequently in 
endurance athletes is not supported in the literature, while the claim that people with the ​RR 
genotype are likely to see increased benefit from explosive training is more extensively 
supported. Claims that ​AGT​ alleles are associated with​ ​power and strength sports and ​IL6 ​alleles 
with inflammatory responses are supported by literature. Additionally, claims for alleles 
associated with fat sensitivities from ​FTO ​and ​PPARG ​are relatively well supported by the 
literature as well. 
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Study Limitations 
This study examined only the information available to a consumer before a test is 
purchased. Purchasing tests from a sample of DTC genetic fitness companies would have 
permitted us to assess how results are presented and what explanatory information is available 
and how that compares to relevant scientific literature.  
Practice Implications 
Our study suggests that those purchasing these tests for recreational purposes should be 
aware that the tests, often expensive, provide almost entirely inconclusive results. Ideally, 
consumers may be made aware that all DTC companies are not created equal and this study may 
provide a helpful guide for their own research and comparison shopping. Additionally, this work 
may provide genetic counselors with an up to date reference for answering questions about the 
types and limitations of genetic fitness tests.  
Research Recommendations 
More scientific research is still needed to better understand genetic differences associated 
with athletic traits. It appears there is a consensus in the scientific community regarding the 
inherent predictive limitations of the current data on polymorphisms related to 
athletics—including the most well established as well as the more controversial associations. 
Larger, racially diverse cohorts are needed as well as cohorts with varying athletic levels, from 
people who do not work out at all to those who are not elite athletes, but workout three to five 
times per week. DTC genetic fitness testing for athletic ability may eventually play a useful role 
in an assessment of fitness potential. However, the scientific community is rightly concerned 
about the legitimacy of what companies are marketing and selling the consumer as representing 
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the general population (as opposed to elite athletes). Given the lack of basic information 
available on the websites, we cannot fully assess the basis of their claims, and can only generally 
express skepticism about the product as being limited in value according to what is currently 
known. DTC genetic testing companies should be encouraged to be more honest and transparent 


















ANALYSIS OF DTC GENETIC FITNESS TESTS    
References 
Ahmetov, I., Druzhevskaya, A., Astratenkova, I., Rogozkin, V., Popov, D., & Vinogradova, O.  
(2010). The actn3 r577x polymorphism in russian endurance athletes. ​British Journal of  
Sports Medicine,​ ​44​(9), 649-652. doi:10.1136/bjsm.2008.051540 
Ahmetov, I., Mozhayskaya, I., Lyubaeva, E., Vinogradova, O., & Rogozkin, V. (2008). Pparg  
gene polymorphism and locomotor activity in humans. ​Bulletin of Experimental Biology  
and Medicine,​ ​146​(5), 630-2. 
Ahmetov, I. I., & Fedotovskaya, O. N. (2015). Current progress in sports genomics. In ​Advances  
in clinical chemistry​ (Vol. 70, pp. 247-314). Elsevier. 
Ahmetov, I. I., Vinogradova, O. L., & Williams, A. G. (2012). Gene polymorphisms and  
fiber-type composition of human skeletal muscle. ​International journal of sport nutrition  
and Exercise metabolism, 22​(4), 292-303. 
Aleksandra, Z., Zbigniew, J., Waldemar, M., Agata, L., Mariusz, K., Marek, S., . . . Paweł, C.  
(2016). The agt gene m235t polymorphism and response of power-related variables to  
aerobic training. ​Journal of Sports Science & Medicine,​ ​15​(4), 616-624. 
Alfred, T., Ben-Shlomo, Y., Cooper, R., Hardy, R., Cooper, C., Deary, I., . . . HALCyon study  
team. (2011). Actn3 genotype, athletic status, and life course physical capability:  
Meta-analysis of the published literature and findings from nine studies. ​Human  
Mutation,​ ​32​(9), 1008-18. doi:10.1002/humu.21526 
Allyse, M. A., Robinson, D. H., Ferber, M. J., & Sharp, R. R. (2018, January).  
Direct-to-consumer testing 2.0: emerging models of direct-to-consumer genetic testing.  
In ​Mayo clinic proceedings​ (Vol. 93, No. 1, pp. 113-120). Elsevier. 
ANALYSIS OF DTC GENETIC FITNESS TESTS    
Brooks, M. A., & Tarini, B. A. (2011). Genetic testing and youth sports. ​JAMA, 305​(10),  
1033-1034. 
Caulfield, T. (2011). Predictive or preposterous? The marketing of DTC genetic testing. ​Journal  
of Science Communication, 10​(3), C02. 
Caulfield, T., & McGuire, A. (2012). Direct-to-consumer genetic testing: Perceptions, problems,  
and policy responses. ​Annual Review of Medicine,​ ​63​(1), 23-33.  
doi:10.1146/annurev-med-062110-123753 
Drozdovska, S. B., Dosenko, V. E., Ahmetov, I. I., & Ilyin, V. (2013). The association of gene  
polymorphisms with athlete status in Ukrainians. ​Biology of sport​, ​30​(3), 163. 
Druzhevskaya, A., Ahmetov, I., Astratenkova, I., & Rogozkin, V. (2008). Association of the  
actn3 r577x polymorphism with power athlete status in russians. ​European Journal of  
Applied Physiology,​ ​103​(6), 631-634. 
Eynon, N., Bishop, D., Ruiz, J., Femia, P., Pushkarev, V., Dyatlov, D., . . . Lucia, A. (2012). The  
actn3 r577x polymorphism across three groups of elite male european athletes. ​Plos One,  
7​(8). doi:10.1371/journal.pone.0043132 
Eynon, N., Ruiz, J., Meckel, Y., Santiago, C., Fiuza-Luces, C., Gómez-Gallego, F., . . . Lucia, A.  
(2011a). Is the -174 c/g polymorphism of the il6 gene associated with elite power  
performance? a replication study with two different caucasian cohorts. ​Experimental  
Physiology,​ ​96​(2), 156-62. doi:10.1113/expphysiol.2010.055442 
Eynon, N., Morán, M., Birk, R., & Lucia, A. (2011b). The champions' mitochondria: Is it  
genetically determined? a review on mitochondrial dna and elite athletic performance.  
Physiological Genomics,​ ​43​(13), 789-798. doi:10.1152/physiolgenomics.00029.2011 
ANALYSIS OF DTC GENETIC FITNESS TESTS    
Eynon, N., Nasibulina, E., Banting, L., Cieszczyk, P., Maciejewska-Karlowska, A., Sawczuk,  
M., Earnest, C. (2013). The fto a/t polymorphism and elite athletic performance: A study  
involving three groups of european athletes. ​Plos One,​ ​8​(4), 60570.  
doi:10.1371/journal.pone.0060570 
Gottlieb, S. (2017). ​Statement from FDA Commissioner Scott Gottlieb, M.D., on implementation  
of agency’s streamlined development and review pathway for consumer tests that 
evaluate  
genetic health risks. ​Retrieved from ​https://www.fda.gov/news-events /press-  
announcements/statement-fda-commissioner-scott-gottlieb-md-implementation-agencys-s 
treamlined-development-and 
Guth, L., & Roth, S. (2013). Genetic influence on athletic performance. ​Current Opinion in  
Pediatrics,​ ​25​(6), 653-8. doi:10.1097/MOP.0b013e3283659087 
Harris, A., Kelly, S. E., & Wyatt, S. (2013). Counseling customers: emerging roles for genetic  
counselors in the direct-to-consumer genetic testing market. ​Journal of genetic  
counseling, 22​(2), 277-288. 
Hawkins, A., & Ho, A. (2012). Genetic counseling and the ethical issues around direct to  
consumer genetic testing. ​Journal of Genetic Counseling,​ ​21​(3), 367-373.  
doi:10.1007/s10897-012-9488-8 
Kikuchi, N., & Nakazato, K. (2015). Effective utilization of genetic information for athletes and  
coaches: Focus on actn3 r577x polymorphism. ​Journal of Exercise Nutrition &  
Biochemistry,​ ​19​(3), 157-64. doi:10.5717/jenb.2015.15093001 
Kyle, G., Bryon, R., Michael, D., Jonathon, P., Mark, A., & Gianni, P. (2011). Il-6 induced stat3  
ANALYSIS OF DTC GENETIC FITNESS TESTS    
signalling is associated with the proliferation of human muscle satellite cells following  
acute muscle damage. ​Plos One,​ ​6​(3). doi:10.1371/journal.pone.0017392 
Lee, F. X., Houweling, P. J., North, K. N., & Quinlan, K. G. (2016). How does α-actinin-3  
deficiency alter muscle function? Mechanistic insights into ACTN3, the ‘gene for speed’.  
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1863​(4), 686-693. 
Leońska-Duniec, A., Ahmetov, I., & Zmijewski, P. (2016). Genetic variants influencing  
effectiveness of exercise training programmes in obesity — an overview of human  
studies. ​Biology of Sport / Institute of Sport,​ ​33​(3), 207-214. 
Lippi, G., Favaloro, E., & Plebani, M. (2011). Direct-to-consumer testing: More risks than  
opportunities: Direct-to-consumer testing. ​International Journal of Clinical Practice,  
65​(12), 1221-1229. doi:10.1111/j.1742-1241.2011.02774.x 
Ma, F., Yang, Y., Li, X., Zhou, F., Gao, C., Li, M., & Gao, L. (2013). The association of sport  
performance with ace and actn3 genetic polymorphisms: A systematic review and  
meta-analysis. ​Plos One,​ ​8​(1). doi:10.1371/journal.pone.0054685 
Mattsson, C. M., Wheeler, M. T., Waggott, D., Caleshu, C., & Ashley, E. A. (2016). Sports  
genetics moving forward: lessons learned from medical research. ​Physiological  
genomics, 48​(3), 175-182. 
Murray, A., Carson, M., Morris, C., & Beckwith, J. (2010). Illusions of scientific legitimacy:  
Misrepresented science in the direct-to-consumer genetic-testing marketplace. ​Trends in  
Genetics,​ ​26​(11), 459-461. 
Nazarov, I., Woods, D., Montgomery, H., Shneider, O., Kazakov, V., Tomilin, N., & Rogozkin, 
V.  
ANALYSIS OF DTC GENETIC FITNESS TESTS    
(2001). The angiotensin converting enzyme i/d polymorphism in russian athletes.  
European Journal of Human Genetics,​ ​9​, 797-801. 
North, K. N., Yang, N., Wattanasirichaigoon, D., Mills, M., Easteal, S., & Beggs, A. H. (1999).  
A common nonsense mutation results in α-actinin-3 deficiency in the general population.  
Nature genetics, 21​(4), 353. 
Papadimitriou, I. D., Lucia, A., Pitsiladis, Y. P., Pushkarev, V. P., Dyatlov, D. A., Orekhov, E. 
F.,  
... & Cieszczyk, P. (2016). ACTN3 R577X and ACE I/D gene variants influence  
performance in elite sprinters: a multi-cohort study. ​BMC genomics, 17​(1), 285. 
Phillips, A. M. (2016). Only a click away—DTC genetics for ancestry, health, love… and more:  
A view of the business and regulatory landscape. ​Applied & translational genomics, 8​,  
16-22. 
Pickering, C., Suraci, B., Semenova, E. A., Boulygina, E. A., Kostryukova, E. S., Kulemin, N.  
A., ... & Lyubaeva, E. V. (2019). A Genome-Wide Association Study of sprint  
performance in elite youth football players. ​The Journal of Strength & Conditioning  
Research, 33​(9), 2344-2351. 
Puthucheary, Z., Skipworth, J., Rawal, J., Loosemore, M., Van Someren, K., & Montgomery, H.  
(2011). The ace gene and human performance: 12 years on. ​Sports Medicine,​ ​41​(6),  
433-448. doi:10.2165/11588720-000000000-00000 
Rankinen, T., Wolfarth, B., Simoneau, J., Maier-Lenz, D., Rauramaa, R., Rivera, M., . . .  
Bouchard, C. (2000). No association between the angiotensin-converting enzyme id  
polymorphism and elite endurance athlete status. ​Journal of Applied Physiology  
ANALYSIS OF DTC GENETIC FITNESS TESTS    
(bethesda, Md. : 1985),​ ​88​(5), 1571-5. 
Ruiz, J., Buxens, A., Artieda, M., Arteta, D., Santiago, C., Rodríguez-Romo, G., . . . Lucia, A.  
(2010). The −174 g/c polymorphism of the il6 gene is associated with elite power  
performance. ​Journal of Science and Medicine in Sport,​ ​13​(5), 549-553.  
doi:10.1016/j.jsams.2009.09.005 
Saunders, C., September, A., Xenophontos, S., Cariolou, M., Anastassiades, L., Noakes, T., &  
Collins, M. (2007). No association of the actn3 gene r577x polymorphism with  
endurance performance in ironman triathlons. ​Annals of Human Genetics,​ ​71​(6),  
777-781. 
Spencer, E., & Topol, E. (2019). Direct to consumer fitness dna testing. ​Clinical Chemistry,  
65​(1), 45-47. 
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014). Il-6 in inflammation, immunity, and disease.  
Cold Spring Harbor Perspectives in Biology,​ ​6​(10). doi:10.1101/cshperspect.a016295 
Taylor, R., Mamotte, C., Fallon, K., & Van Bockxmeer, F. (1999). Elite athletes and the gene for  
angiotensin-converting enzyme. ​Journal of Applied Physiology,​ ​87​(3), 1035-1037.  
doi:10.1152/jappl.1999.87.3.1035 
Vlahovich, N., Fricker, P. A., Brown, M. A., & Hughes, D. (2017a). Ethics of genetic testing and  
research in sport: a position statement from the Australian Institute of Sport.​ Br J Sports  
Med, 51​(1), 5-11. 
Vlahovich, N., Hughes, D. C., Griffiths, L. R., Wang, G., Pitsiladis, Y. P., Pigozzi, F., ... &  
Eynon, N. (2017b). Genetic testing for exercise prescription and injury prevention:  
AIS-Athlome consortium-FIMS joint statement. ​BMC genomics, 18​(8), 818. 
ANALYSIS OF DTC GENETIC FITNESS TESTS    
Wardle, J., Llewellyn, C., Sanderson, S., & Plomin, R. (2009). The fto gene and measured food  
intake in children. ​International Journal of Obesity,​ ​33​(1), 42-45.  
doi:10.1038/ijo.2008.174 
Webborn, N., Williams, A., McNamee, M., Bouchard, C., Pitsiladis, Y., Ahmetov, I., Ashley, E.,  
Byrne, N., Camporesi, S., Collins, M., Dijkstra, P., Eynon, N., Fuku, N., Garton, F.C., 
Hoppe, N., Holm, S., Kaye, J., Klissouras, V., Lucia, A., Maase, K., Moran, C., North, 
K.N., Pigozzi, F., Wang, G. (2015). Direct-to-consumer genetic testing for predicting 
sports performance and talent identification: Consensus statement. ​British Journal of 
Sports Medicine, 49​(23), 1486-91. doi:10.1136/bjsports-2015-095343 
Weyerstraß, J., Stewart, K., Wesselius, A., & Zeegers, M. (2018). Nine genetic polymorphisms  
associated with power athlete status–a meta-analysis. ​Journal of science and medicine in  
sport​, ​21​(2), 213-220. 
Williams, A. G., Heffernan, S. M., & Day, S. H. (2014). Genetic testing in exercise and  
sport-have direct-to-consumer genetic tests come of age?. ​Science and Sport: Current  
Trends, 2​(1), 3-9. 
Yang, L., & Song, G. (2016). Hall of fame among pro-inflammatory cytokines: Interleukin-6  
gene and its transcriptional regulation mechanisms. ​Frontiers in Immunology,​ ​(2016)​.  
doi:10.3389/fimmu.2016.00604 
Zarebska, A., Sawczyn, S., Kaczmarczyk, M., Ficek, K., Maciejewska-Karlowska, A., Sawczuk,  
M., ... & Cieszczyk, P. (2013). Association of rs699 (M235T) polymorphism in the AGT  
gene with power but not endurance athlete status. ​The Journal of Strength &  
Conditioning Research, 27​(10), 2898-2903. 
